MINDY BROWN: Open Payments
NPI 1083704498 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 28 payments from 12 companies in 2025. Trend: 2023 $46 · 2024 $13 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $171 |
| Novo Nordisk Inc | 3 | $165 |
| Amgen Inc. | 2 | $140 |
| Corcept Therapeutics | 3 | $51 |
| Lilly USA, LLC | 2 | $46 |
| Grifols USA, LLC | 1 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $23 |
| Cepheid | 1 | $23 |
| Viatris Specialty LLC | 1 | $22 |
Products named: KRYSTEXXA, Ozempic, QULIPTA, Korlym, VRAYLAR, MOUNJARO, Prolastin-C Liquid, FANAPT.
Industry payments across ID — which companies pay providers there.
